|
1
|
Fehrenbacher L, Spira A, Ballinger M,
Kowanetz M, Vansteenkiste J, Mazieres J, Park K, Smith D,
Artal-Cortes A, Lewanski C, et al POPLAR Study Group, :
Atezolizumab versus docetaxel for patients with previously treated
non-small-cell lung cancer (POPLAR): A multicentre, open-label,
phase 2 randomised controlled trial. Lancet. 387:1837–1846. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Masters GA, Johnson DH and Temin S:
Systemic therapy for stage IV non-small-cell lung cancer: American
Society of Clinical Oncology Clinical Practice Guideline Update. J
Oncol Pract. 12:90–93. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jamal-Hanjani M, Wilson GA, McGranahan N,
Birkbak NJ, Watkins TBK, Veeriah S, Shafi S, Johnson DH, Mitter R,
Rosenthal R, et al TRACERx Consortium, : Tracking the evolution of
non-small-cell lung cancer. N Engl J Med. 376:2109–2121. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gettinger S, Rizvi NA, Chow LQ, Borghaei
H, Brahmer J, Ready N, Gerber DE, Shepherd FA, Antonia S, Goldman
JW, et al: Nivolumab monotherapy for first-line treatment of
advanced non-small-cell lung cancer. J Clin Oncol. 34:2980–2987.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Planchard D, Yokoi T, McCleod MJ, Fischer
JR, Kim YC, Ballas M, Shi K and Soria JC: A phase III study of
durvalumab (MEDI4736) with or without tremelimumab for previously
treated patients with advanced NSCLC: Rationale and protocol design
of the ARCTIC study. Clin Lung Cancer. 17:232–236.e1. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Emdad L, Lebedeva IV, Su ZZ, Gupta P,
Sarkar D, Settleman J and Fisher PB: Combinatorial treatment of
non-small-cell lung cancers with gefitinib and Ad.mda-7 enhances
apoptosis-induction and reverses resistance to a single therapy. J
Cell Physiol. 210:549–559. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cravens SL and Stivers JT: Comparative
effects of ions, molecular crowding, and bulk DNA on the damage
search mechanisms of hOGG1 and hUNG. Biochemistry. 55:5230–5242.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kadıoğlu E, Taçoy G, Özçağlı E, Okyay K,
Akboğa MK, Çengel A and Şardaş S: The role of oxidative DNA damage
and GSTM1, GSTT1, and hOGG1 gene polymorphisms in coronary artery
disease risk. Anatol J Cardiol. 16:931–938. 2016.PubMed/NCBI
|
|
9
|
Alanazi M, Pathan AAK, Shaik JP, Alhadheq
A, Khan Z, Khan W, Al Naeem A and Parine NR: The hOGG1 Ser326Cys
gene polymorphism and breast cancer risk in Saudi population.
Pathol Oncol Res. 23:525–535. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sliwinska A, Kwiatkowski D, Czarny P, Toma
M, Wigner P, Drzewoski J, Fabianowska-Majewska K, Szemraj J, Maes
M, Galecki P, et al: The levels of 7,8-dihydrodeoxyguanosine
(8-oxoG) and 8-oxoguanine DNA glycosylase 1 (OGG1) - A potential
diagnostic biomarkers of Alzheimer's disease. J Neurol Sci.
368:155–159. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li Z, Guan W, Li MX, Zhong ZY, Qian CY,
Yang XQ, Liao L, Li ZP and Wang D: Genetic polymorphism of DNA
base-excision repair genes (APE1, OGG1 and XRCC1) and their
correlation with risk of lung cancer in a Chinese population. Arch
Med Res. 42:226–234. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cao WJ, Lu JZ, Li C, Gao YJ, Lu KQ, Wang
HZ and Wang ZP: The hOGG1 Ser326Cys gene polymorphism and
susceptibility for bladder cancer: A meta-analysis. Int Braz J
Urol. 42:883–896. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sanjari Moghaddam A, Nazarzadeh M, Bidel
Z, Karamatinia A, Darvish H and Mosavi Jarrahi A: hOGG1 gene
polymorphism and breast cancer risk: A systematic review and
meta-analysis study. Breast J. 24:70–73. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang M and Mo R: Association of hOGG1
Ser326Cys polymorphism with colorectal cancer risk: An updated
meta-analysis including 5235 cases and 8438 controls. Tumour Biol.
35:12627–12633. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lukina MV, Kuznetsova AA, Kuznetsov NA and
Fedorova OS: The kinetic analysis of recognition of the damaged
nucleotides by mutant forms of the 8-oxoguanine DNA glycosylase
hOGG1. Russ J Bioorganic Chem. 43:1–12. 2017. View Article : Google Scholar
|
|
17
|
Kohno T, Shinmura K, Tosaka M, Tani M, Kim
SR, Sugimura H, Nohmi T, Kasai H and Yokota J: Genetic
polymorphisms and alternative splicing of the hOGG1 gene, that is
involved in the repair of 8-hydroxyguanine in damaged DNA.
Oncogene. 16:3219–3225. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang W, Dang S, Li Y, Sun M, Jia X, Wang R
and Liu J: hOGG1 Ser326Cys polymorphism and risk of hepatocellular
carcinoma among East Asians: A meta-analysis. PLoS One.
8:e601782013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xie Y, Wu Y, Zhou X, Yao M, Ning S and Wei
Z: Association of polymorphisms hOGGI rs1052133 and hMUTYH
rs3219472 with risk of nasopharyngeal carcinoma in a Chinese
population. Onco Targets Ther. 9:755–760. 2016.PubMed/NCBI
|
|
20
|
Tan H: On the protective effects of gene
SNPs against human cancer. EBioMedicine. 33:4–5. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Corella D, Ramírez-Sabio JB, Coltell O,
Ortega-Azorín C, Estruch R, Martínez-González MA, Salas-Salvadó J,
Sorlí JV, Castañer O, Arós F, et al: Effects of the Ser326Cys
polymorphism in the DNA repair OGG1 gene on cancer, cardiovascular
and all-cause mortality in the PREDIMED study: Modulation by diet.
J Acad Nutr Diet. 118:589–605. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang Y, Gao X, Wei F, Zhang X, Yu J, Zhao
H, Sun Q, Yan F, Yan C, Li H, et al: The hOGG1 Ser326Cys
polymorphism contributes to digestive system cancer susceptibility:
Evidence from 48 case-control studies. Tumour Biol. 36:1029–1038.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhou F, Zhang W, Wei Y, Zhou D, Su Z, Meng
X, Hui L and Tian W: The changes of oxidative stress and human
8-hydroxyguanine glycosylase1 gene expression in depressive
patients with acute leukemia. Leuk Res. 31:387–393. 2007.
View Article : Google Scholar : PubMed/NCBI
|
